XENETIC BIOSCIENCES INC's ticker is XBIO and the CUSIP is 984015503. A total of 15 filers reported holding XENETIC BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40 | -2.4% | 99,507 | -30.6% | 0.00% | – |
| Q4 2022 | $41 | -99.9% | 143,400 | +24.6% | 0.00% | – |
| Q3 2022 | $62,000 | -48.8% | 115,100 | -23.8% | 0.00% | – |
| Q2 2022 | $121,000 | -37.9% | 151,058 | -21.1% | 0.00% | – |
| Q1 2022 | $195,000 | -42.1% | 191,407 | -26.7% | 0.00% | – |
| Q4 2021 | $337,000 | -60.8% | 261,223 | -37.6% | 0.00% | -100.0% |
| Q3 2021 | $859,000 | +198.3% | 418,890 | +196.6% | 0.00% | – |
| Q2 2021 | $288,000 | -47.4% | 141,221 | -43.8% | 0.00% | -100.0% |
| Q1 2021 | $548,000 | +57.9% | 251,149 | +47.6% | 0.00% | – |
| Q4 2020 | $347,000 | +542.6% | 170,200 | +187.5% | 0.00% | – |
| Q3 2020 | $54,000 | -69.5% | 59,209 | -65.8% | 0.00% | – |
| Q2 2020 | $177,000 | +45.1% | 173,197 | +5.5% | 0.00% | – |
| Q1 2020 | $122,000 | -29.9% | 164,117 | +35.9% | 0.00% | – |
| Q4 2019 | $174,000 | – | 120,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 26,991 | $55,000 | 0.01% |
| Steward Partners Investment Advisory, LLC | 25,000 | $51,000 | 0.00% |
| VANGUARD GROUP INC | 90,724 | $185,000 | 0.00% |
| UBS Group AG | 5,210 | $11,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,000 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 85 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 50,510 | $103,000 | 0.00% |
| MORGAN STANLEY | 2,261 | $5,000 | 0.00% |